ArticleOncology letters2025

Patients with T4N0 and T1‑3N1 colon cancer and a high preoperative carcinoembryonic antigen level benefit from adjuvant chemotherapy with oxaliplatin for 6 months.

Hiroyuki Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.